Literature DB >> 6141134

Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit.

P Ferenci, S C Pappas, P J Munson, E A Jones.   

Abstract

The status of the excitatory glutamatergic neurotransmitter system in hepatic encephalopathy has been studied. Synaptic membranes (SM) were prepared from the brains of normal rabbits, hyperammonemic normal rabbits, and rabbits with fulminant hepatic failure. Data on the specific binding of glutamate to SM indicated that fulminant hepatic failure was associated with a decrease in the number of glutamate receptors on SM from cerebral cortex, cerebellum, and particularly the hippocampus, without any associated change in the affinity of these receptors. In contrast, hyperammonemia was associated with an increase in the affinity and no decrease in the number of glutamate receptors on SM from the hippocampus. These findings indicate that the effects of hyperammonemia and fulminant hepatic failure on cerebral glutamate receptors are fundamentally different. The decreased number of glutamate receptors in hepatic encephalopathy might reflect a decreased sensitivity of glutamatergic neurons to glutamate-mediated neural excitation, a phenomenon that could contribute to the neural inhibition of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6141134     DOI: 10.1002/hep.1840040105

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.

Authors:  F Violi; C Alessandri; D Ferro; M Saliola; C Cordova; A Musca; F Balsano
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

2.  Neuroactive amino acids in hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

3.  L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity.

Authors:  V Felipo; M D Miñana; H Cabedo; S Grisolía
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

4.  Brain cortical amino acids measured by intracerebral dialysis in portacaval shunted rats.

Authors:  U Tossman; A Delin; L S Eriksson; U Ungerstedt
Journal:  Neurochem Res       Date:  1987-03       Impact factor: 3.996

Review 5.  Supersensitivity of GABA-A receptors in hepatic encephalopathy.

Authors:  M Baraldi
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

6.  Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.

Authors:  R J de Knegt; J Kornhuber; S W Schalm; K Rusche; P Riederer; J Tan
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

Review 7.  Natural endogenous ligands for benzodiazepine receptors in hepatic encephalopathy.

Authors:  M Baraldi; R Avallone; L Corsi; I Venturini; C Baraldi; M L Zeneroli
Journal:  Metab Brain Dis       Date:  2008-12-11       Impact factor: 3.584

8.  CNQX binding to non-NMDA glutamate receptors in canine cerebro-cortical crude synaptosomal membranes: pharmacological characterization and comparison of binding parameters in dogs with congenital portosystemic encephalopathy and control dogs.

Authors:  J E Maddison; W E Watson; G A Johnston
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

9.  The two catalytic components of the 2-oxoglutarate dehydrogenase complex in rat cerebral synaptic and nonsynaptic mitochondria: comparison of the response to in vitro treatment with ammonia, hyperammonemia, and hepatic encephalopathy.

Authors:  L Faff-Michalak; J Albrecht
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

10.  Ammonia regulation of phosphate-activated glutaminase displays regional variation and impairment in the brain of aged rats.

Authors:  D R Wallace; R Dawson
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.